Tag: Alzheimer’s

  • Why Cassava Sciences Could be a Buy Again on Weakness

    Why Cassava Sciences Could be a Buy Again on Weakness

    On July 22, we mentioned Cassava Sciences was one of the hottest stocks on the market. In fact, since mentioning it, the stock ran from about $108 to $144.63. All thanks to a build-up of excitement ahead of its presentation at the 2021 Alzheimer’s Association International Conference.  Today, though, the stock is down about $11…

  • This is Why Cassava Sciences (SAVA) Could Explode — Again

    This is Why Cassava Sciences (SAVA) Could Explode — Again

    Cassava Sciences (SAVA) is soaring again. After pulling back to strong support around $91, the stock is back to $108 thanks to new price targets, and progress on its lead drug candidate for Alzheimer’s. H.C. Wainwright raised its price target to $124 on SAVA.  Cantor Fitzgerald raised its target to $100.  Better, the company already…